AstraZeneca logo
Join our mailing list
AZ Oncology UK logo
  • Breast cancer
    • Overview
    • Spotlight
    • Events
    • Medicines
  • Haematology
  • Lung cancer
    • Overview
    • Spotlight
    • Events
    • Medicines
  • Ovarian cancer
    • Overview
    • Spotlight
    • Resources
    • Events
    • Medicines
  • Prostate cancer
    • Spotlight
    • Medicines
  • Contact us
  • medical-education-and-products

Site map

 

Home

 

Join our mailing list

 

Contact Us

 

Report adverse event

 

Legal Notice

 

Privacy Policy

 

Cookie Policy

Breast cancer

 

Haematology

 

Lung cancer

 

Ovarian cancer

 

Prostate cancer

This website is intended for UK healthcare professionals only

© AstraZeneca 2024. All rights reserved.

AstraZeneca logo

GB-64175 April 2025

Legal Notice


Privacy Potice


Cookie Policy


Site Map


Contact Us

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in the Google Play or Apple Store.

Adverse events should also be reported to AstraZeneca by visiting https://contactazmedical.astrazeneca.com or by calling 0800 783 0033.

Adverse events relating to ENHERTU should also be reported to Daiichi Sankyo UK Pharmacovigilance on 0800 028 5122 or by email tomailto:pharmacovigilance@daiichi-sankyo.co.uk

As ENHERTU is a biological medicine, healthcare professionals should report adverse reactions by brand name and batch number

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in the Google Play or Apple Store. Adverse events should also be reported to AstraZeneca by visiting https://contactazmedical.astrazeneca.com or by calling 0800 783 0033.

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in the Google Play or Apple Store Adverse events relating to AstraZeneca medicines should also be reported to AstraZeneca by visiting https://contactazmedical.astrazeneca.com or by calling 0800 783 0033 Adverse events relating to ENHERTU should also be reported to Daiichi Sankyo UK Pharmacovigilance on 0800 028 5122 or by email to pharmacovigilance@daiichi-sankyo.co.uk As ENHERTU is a biological medicine, healthcare professionals should report adverse reactions by brand name and batch number

© AstraZeneca 2024. All rights reserved.

GB-64175 April 2025

This is an AstraZeneca UK website

The content on this website is intended for UK Healthcare Professionals only. The website contains both promotional and non-promotional content.